Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Diacerein in adults with type 2 diabetes receiving oral antihyperglycemic drugs
RBR-29j956Phase 3Completed
- Sponsor
- Hospital de Clínicas de Porto Alegre
- Start
- Mar 2014
- Modality
- DNA Intercalators/Alkylators → Nucleic Acid-Directed Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 3 trial of diacerein in type 2 diabetes mellitus (T2DM) (2 arms), sponsored by Hospital de Clínicas de Porto Alegre. Started Mar 2014; status: completed.
02
Drugs
diacerein
03
Conditions
type 2 diabetes mellitus (T2DM)
Beyond the preview
Go deeper on RBR-29j956.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on RBR-29j956.